|Bid||11.89 x 800|
|Ask||12.75 x 800|
|Day's range||11.98 - 12.24|
|52-week range||11.03 - 18.00|
|Beta (5Y monthly)||1.66|
|PE ratio (TTM)||N/A|
|Earnings date||22 Mar 2022 - 28 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||19.00|
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. While...
Joining me on today's call are Tony Koblish, president and chief executive officer; and Roberto Cuca, chief operating officer and chief financial officer. Before we begin, I'd like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events.
TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of -9.62% and 4.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?